Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Chr. Hansen Extends its Probiotics Family - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Chr. Hansen Extends its Probiotics Family

Chr. Hansen has signed an exclusive agreement with biotech company Probiomics Ltd., securing the rights to market the patented probiotic strain Lactobacillus fermentum PCC, which has documented benefits to immune health.

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Chr. Hansen has signed an exclusive agreement with biotech company Probiomics Ltd., securing the rights to market the patented probiotic strain Lactobacillus fermentum PCC, which has documented benefits to immune health.

“Signing the agreement is the result of more than two years of negotiations between Chr. Hansen and Probiomics—and the beginning of a fantastic partnership,” said Sune Schmoelker, director, Commercial Development, Human Health. “We cannot wait to introduce the PCC strain to Chr Hansen’s probiotic customers.

Ashok Jairath, CFO at Probiomics Ltd., added: “Chr. Hansen being the global market leader within probiotics, this is the perfect partner for us to distribute L. fermentum PCC.”

Several clinical studies in various indication areas have been conducted involving PCC, which has shown to be effective in relation to atopic dermatitis, as an adjuvant to flu vaccine, and in supporting the immune response in athletes.

Just a few months ago the Australian Institute of Sport (AIS) and Chr. Hansen finalized a larger immune study in a group of 99 sports athletes. The double-blinded, placebo-controlled study documented that PCC was effective in reducing the severity and illness load of chest infection and medication use associated with respiratory tract infections (colds and flus) in males. Furthermore, the researchers found that consuming PCC moderated the negative effects of exercise stress on the immune system. The study is expected to be published in 2010.

It was the second study in athletes clearly supportive of PCC in relation to immune health.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters